COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Mitra Biotech develops CANScript, an ex vivo tumor-response platform that personalizes cancer therapy selection and accelerates drug development, conducting clinical studies and commercial operations in the US and India.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors